Ming-Chyi Pai

查看斯高帕斯 (Scopus) 概要

電子郵件pairmail.ncku.edutw

h-index

每年研究成果

94 Article
7 Review article
6 Conference contribution
2 Paper
更多

7結果

篩選

2024
Application of blood-based biomarkers of Alzheimer's disease in clinical practice: Recommendations from Taiwan Dementia Society
Cheng, Y. W., Lin, Y. J., Lin, Y. S., Hong, W. P., Kuan, Y. C., Wu, K. Y., Hsu, J. L., Wang, P. N., Pai, M. C., Chen, C. S., Fuh, J. L., Hu, C. J. & Chiu, M. J., 2024, (Accepted/In press) 於: Journal of the Formosan Medical Association.
研究成果: Review article › 同行評審

開啟存取
1 引文斯高帕斯（Scopus）
2022
The Effect of Agomelatine in Behavioral and Psychological Symptoms of Dementia
Wang, C. S. M., Cheng, K. S., Tang, C. H., Pai, M. C., Chen, P. L. & Chien, P. F., 2022, 於: Clinical Psychopharmacology and Neuroscience. 20, 4, p. 701-714 14 p.
研究成果: Review article › 同行評審

開啟存取
2021
Taiwan Dementia treatment guideline
Huang, L. K., Chiu, P. Y., Yeh, Y. C., Chang, Y. T., Jhang, K. M., Chen, C. S., Chao, S. P., Lin, C. P., Chang, W. H., Hong, W. P., Huang, M. F., Lu, C. H., Lee, Y. T., Hung, C. H., Liu, C. K., Lin, W., Chang, C. C., Hu, C. J. & Pai, M. C., 2021 10月, 於: International Journal of Gerontology. 15, 4, p. 292-300 9 p.
研究成果: Review article › 同行評審
3 引文斯高帕斯（Scopus）
2020
Tackling challenges in care of Alzheimer's disease and other dementias amid the COVID-19 pandemic, now and in the future
Mok, V. C. T., Pendlebury, S., Wong, A., Alladi, S., Au, L., Bath, P. M., Biessels, G. J., Chen, C., Cordonnier, C., Dichgans, M., Dominguez, J., Gorelick, P. B., Kim, S. Y., Kwok, T., Greenberg, S. M., Jia, J., Kalaria, R., Kivipelto, M., Naegandran, K., Lam, L. C. W., 及其他15Lam, B. Y. K., Lee, A. T. C., Markus, H. S., O'Brien, J., Pai, M. C., Pantoni, L., Sachdev, P., Skoog, I., Smith, E. E., Srikanth, V., Suh, G. H., Wardlaw, J., Ko, H., Black, S. E. & Scheltens, P., 2020 11月, 於: Alzheimer's and Dementia. 16, 11, p. 1571-1581 11 p.
研究成果: Review article › 同行評審

開啟存取
122 引文斯高帕斯（Scopus）
2017
Rivastigmine: The advantages of dual inhibition of acetylcholinesterase and butyrylcholinesterase and its role in subcortical vascular dementia and parkinson’s disease dementia
Kandiah, N., Pai, M. C., Senanarong, V., Looi, I., Ampil, E., Park, K. W., Karanam, A. K. & Christopher, S., 2017, 於: Clinical Interventions in Aging. 12, p. 697-707 11 p.
研究成果: Review article › 同行評審

開啟存取
157 引文斯高帕斯（Scopus）
2016
Clinical Recommendations for the Use of Donepezil 23 mg in Moderate-to-Severe Alzheimer's Disease in the Asia-Pacific Region
Sabbagh, M., Han, S., Kim, S., Na, H. R., Lee, J. H., Kandiah, N., Phanthumchinda, K., Suthisisang, C., Senanarong, V., Pai, M. C., Narilastri, D., Sowani, A. M., Ampil, E. & Dash, A., 2016 9月 9, 於: Dementia and Geriatric Cognitive Disorders Extra. 6, 3, p. 382-395 14 p.
研究成果: Review article › 同行評審

開啟存取
10 引文斯高帕斯（Scopus）
2008
Delusions and visual hallucinations in dementia patients: Focus on personal history of the patients
Pai, M. C., 2008, 於: Tohoku Journal of Experimental Medicine. 216, 1, p. 1-5 5 p.
研究成果: Review article › 同行評審
8 引文斯高帕斯（Scopus）

白 明奇

研究成果

搜尋結果

Application of blood-based biomarkers of Alzheimer's disease in clinical practice: Recommendations from Taiwan Dementia Society

The Effect of Agomelatine in Behavioral and Psychological Symptoms of Dementia

Taiwan Dementia treatment guideline

Tackling challenges in care of Alzheimer's disease and other dementias amid the COVID-19 pandemic, now and in the future

Rivastigmine: The advantages of dual inhibition of acetylcholinesterase and butyrylcholinesterase and its role in subcortical vascular dementia and parkinson’s disease dementia

Clinical Recommendations for the Use of Donepezil 23 mg in Moderate-to-Severe Alzheimer's Disease in the Asia-Pacific Region

Delusions and visual hallucinations in dementia patients: Focus on personal history of the patients

白明奇